Need Help?
No Article Versions Notes Found
Cite
Morgillo, F.; De Vita, F.; Antoniol, G.; Orditura, M.; Auriemma, P.P.; Diadema, M.R.; Lieto, E.; Savastano, B.; Festino, L.; Laterza, M.M.; et al. Serum Insulin-Like Growth Factor 1 Correlates with the Risk of Nodal Metastasis in Endocrine-Positive Breast Cancer. Curr. Oncol. 2013, 20, 283-288. https://doi.org/10.3747/co.20.1380
Morgillo F, De Vita F, Antoniol G, Orditura M, Auriemma PP, Diadema MR, Lieto E, Savastano B, Festino L, Laterza MM, et al. Serum Insulin-Like Growth Factor 1 Correlates with the Risk of Nodal Metastasis in Endocrine-Positive Breast Cancer. Current Oncology. 2013; 20(4):283-288. https://doi.org/10.3747/co.20.1380
Chicago/Turabian StyleMorgillo, F., F. De Vita, G. Antoniol, M. Orditura, P.P. Auriemma, M.R. Diadema, E. Lieto, B. Savastano, L. Festino, M.M. Laterza, and et al. 2013. "Serum Insulin-Like Growth Factor 1 Correlates with the Risk of Nodal Metastasis in Endocrine-Positive Breast Cancer" Current Oncology 20, no. 4: 283-288. https://doi.org/10.3747/co.20.1380
APA StyleMorgillo, F., De Vita, F., Antoniol, G., Orditura, M., Auriemma, P. P., Diadema, M. R., Lieto, E., Savastano, B., Festino, L., Laterza, M. M., Fabozzi, A., Ventriglia, J., Petrillo, A., Ciardiello, F., Barbarisi, A., & Iovino, F. (2013). Serum Insulin-Like Growth Factor 1 Correlates with the Risk of Nodal Metastasis in Endocrine-Positive Breast Cancer. Current Oncology, 20(4), 283-288. https://doi.org/10.3747/co.20.1380
